Roivant Sciences Ltd.

Ownership Transactions Reported by 23 Insiders

Symbol
ROIV on Nasdaq
Industry
Pharmaceutical Preparations
Location
Clarendon House, 2 Church Street, Hamilton Hm11, Bermuda

Insiders trading volume in the past year

Roivant Sciences Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dexcel Pharma Technologies Ltd. 10%+ Owner $1.06B Nov 10, 2022
Daniel Allen Gold Director $898M -$116M -11.4% Mar 7, 2024
QVT Financial LP Director by Deputization, 10%+ Owner $781M -$116M -12.9% Mar 7, 2024
SVF Investments (UK) Ltd 10%+ Owner $756M -$126M -14.3% Sep 28, 2023
Sumitomo Chemical Co., Ltd. 10%+ Owner $737M Jun 22, 2023
Vivek Ramaswamy 10%+ Owner $696M -$33.2M -4.54% Apr 2, 2024
Keith S. Manchester Director $575M -$79.7M -12.2% Mar 7, 2024
Mayukh Sukhatme Pres&Chief Investment Officer, Director $261M Jul 26, 2024
Matthew Gline CEO, Director $210M Aug 20, 2024
Viking Global Investors Lp 10%+ Owner $133M Jun 22, 2023
Viking Global Performance Llc 10%+ Owner $133M Jun 22, 2023
Benjamin Zimmer President, Roivant Health $12.1M Oct 1, 2021
Eric Venker President & COO $7.34M -$20.1M -73.2% Aug 20, 2024
Rakhi Kumar Chief Accounting Officer $3.44M Aug 20, 2024
Richard Pulik Cfo $3.43M Aug 28, 2024
Ilan Oren Director $910K Jul 23, 2024
James C. Momtazee Director $836K Jul 23, 2024
Andrew Lo Director $540K Sep 15, 2022
Melissa Epperly Director $256K Jul 23, 2024
Meghan Fitzgerald Director $151K Apr 24, 2024
Masayo Tada Director Oct 1, 2021
Patrick Machado Director Oct 1, 2021
Hiroshi Nomura Director Sep 16, 2022

Recent Insider Transactions by Companies or Individuals for Roivant Sciences Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.